Paracetamol/ acetaminophen/ apap toxicity / overdose approach

1. A Case !
A 27 years old male presents to the emergency department
with emesis, abdominal pain an altered mental status and
malaise.
He has recently been depressed.
Many empty bottles of different drugs were found in his
bedroom
There’s no further history available

2. Symptomatic treatment
and sent home
Toxicology but NO
overdose founded

3. Suspected drug toxicity from one of the mostly used over-the
counter drug … paracetamol

4. Acetaminophen toxicity
Presented by: Dr.Alyaa Zuhair (medical intern)
Supervised by: Dr.Mohammed Almattar

5. Prevalence
01 Pharmacokinetics
02
Clinical picture
03 Management
04

6. Prevalence
In the United States, acetaminophen toxicity has
replaced viral hepatitis as the most common
cause of acute liver failure
01
Results of a study conducted in KSA showed :
The most frequent agent in poisoning for both
groups was acetaminophen

8. Causes of high prevalence
over the
counter drugs
Underestimate
it’s toxicity
acetaminophen
is found in
more than one
medication they
are using

9. Why it’s important to
recognize paracetamol
toxicity??
If overdose is identified early enough, mortality
rates are extremely low. However, once acute
liver failure has developed, mortality is
approximately 28 percent, and a third of patients
require liver transplantation

10. 1- Analgesic + Antipyretic
2-Excellent safety profile.
3- Pediatrics Dose:10 to 15
mgkg
Adult dose: 325 to 1000 mgdose
What’s acetaminophen?
Maximum recommended dose:
Pediatrics: 80mgkg
Adults 4 mg

12. 1- Excessive intake (mc)
2- delay in treatment
3- Excessive CYP450 activity .
4-Decrease capacity of glucurnidation & sulfation
5- depletion of glutathione stores
Factor’s influence toxicity
Acute Alcohol ingestion Chronic Alcohol ingestion
protective by competing w
for CYP2E1 = decreasing
the amount of NAPQI
produced.
(18 or more standard alcoholic drinks [250 mg/dL])
increases the activity of CYP2E1
activity and depletes glutathione
stores and synthesis(in overdose
therapeutic dose .

13. Clinical
features

14. Histologic changes in the liver vary from
cytolysis to centrilobular necrosis. The
centrilobular region (zone III) is
preferentially involved because it is the
area of greatest concentration of CYP2E1
and therefore the site of maximal
production of NAPQI. Histologic recovery
lags behind clinical recovery and may
take up to three months.

15. INVESTIGATIoNS:
1- History: Time , co-ingestion, intent of use (ie, suicidal or not),
pattern of use (eg, single or repeated doses), time , co-
morbidties , risk factors.
2-serum acetaminophen
3- labs
If established toxicity, or predicted to develop toxicity based on
history and initial serum acetaminophen concentration:
electrolytes, blood urea nitrogen and creatinine, serum total
bilirubin level, prothrombin time (PT) with international
normalized ratio (INR), aspartate aminotransferase (AST),
alanine aminotransferase (ALT), amylase, and urinalysis.
- intentional ingestions or unreliable histories, toxic screening of
blood and urine for other ingested drugs should be performed

16. Evaluation and diagnosis

17. ABC
Management
Stabilization
ACTIVATED
CHARCOAL
Decontamination
N-ACETYL CYSTINE
Antidote
Give activated charcoal (AC)
50 g to all adult patients
presenting within 4 hours of
ingestion, unless
contraindicated; AC may be
useful for coingestants
beyond 4 hours
1- when APAP conce drawn
at >4hr of single acute
ingestion.
2- APAP conce in unknown
- late.
3- Known of case of
ingestion >10mcgml
4-Hepatotoxicity + Hx of
APAP.
5- Hx or suspected+ RF+
serum conce 10 mcg

18. What ?
When ?
How much ?
LFT Hepatotoxicity ?

19. How much ?
- Unlikely from single dose less than 150 mgkg
- Likely 250 mgkg
- Unlikely from single dose less 7.5 - 10 g
- Likely 12 gkg

20. When ?

21. Liver transplantation and liver failure

22. Thanks for
your attention
Sources :
1.uptodate
2. Medscape